Best start-up companies in Menlo Park, CA

Deliv is a crowdsourced, same-day delivery service that extends the reach of omnichannel retailers and provides their customers with an even more exceptional shopping experience. The company helps retailers enhance their customer experience by giving customers the choice to receive their items whenever and wherever they want. Deliv allows retailers to offer their customers a same-day delivery option as they shop from their website, mobile app or even when they are shopping in their physical brick and mortar stores. The same-day delivery button is simply added into the existing checkout process which allows the retailer to maintain ownership and data from each customer transaction. All same-day delivery orders (whether purchased online or in the store) are fulfilled and delivered from local brick and mortar stores, which now allow retailers' stores to strategically become local distribution centers. This allows retailers to deliver faster and cheaper and in a more convenient way than any pure play eCommerce player like Amazon. Deliv has partnered with nearly 100 national and regional omnichannel retailers, as well as the four largest mall operators in the U.S., Simon Property Group, Macerich, Westfield and General Growth Properties. These mall operators manage close to 800 malls across the country, and extend this offering to all of its tenant retailers. Deliv is currently live with almost 100 retailers in nine malls across the four mall operators in five geographies within California and Illinois. Deliv is quickly expanding to dozens of other geographies nationwide. Deliv's crowdsourced drivers are made up of highly educated, experienced customer service and sales personnel. They are rated by customers so the platform is able to prioritize the allocation of jobs to those with the highest ratings. The Deliv platform incorporates smart routing and full transparency including the ability for shoppers to watch their delivery on a map real time from pickup to delivery to their doorstep. To date, Deliv has raised $12.5 million from traditional, institutional and strategic investors including the four mall operators, Simon, Macerich, Westfield and GGP, as well as General Catalyst Partners, Operators Fund, PivotNorth Capital, RPM Ventures and Upfront Ventures.

Yotascale, a leader in Cost Management for AWS, provides cloud operations and finance teams predictable cloud costs. Cost allocation, visibility, planning, and optimization are key features of Yotascale software that enable an effective cost management strategy. Enterprises deploy Yotascale software to bridge the gap between CloudOps, engineering, and finance teams to fulfill fiscal responsibility while taking advantage of the agility of the cloud.

CipherTrace enables the blockchain economy by protecting cryptocurrency companies and financial institutions from security and compliance risks. Years of research have gone into developing the world's most complete and accurate cryptocurrency intelligence and forensics, covering more than 800 currencies. This visibility into the blockchain and virtual asset businesses helps protect banks and exchanges from cryptocurrency laundering risks, while protecting user privacy. CipherTrace also works with government agencies to bridge the gaps between regulation and the world of cryptocurrencies and blockchain.

Kespry's aerial intelligence platform is transforming how organizations capture, analyze and share insights about their business, providing the information they need to accelerate their operations. Purpose-built for industrial use yet simple enough for any user, a wide variety of industries rely on Kespry to solve business-critical problems. Delivering a fully integrated solution from drone data capture to industry-specific analytics, Kespry serves customers across North America, Europe and Australia, including John Deere, Hancock Claims Consultants, Catastrophe Response Unit (CRU), Fluor, Lehigh Hanson/Heidelberg, and Colas USA.

Provider of on demand drug delivery platform intended to create a better experience for patients at a lower price. The company's prescription delivery service offers same-day delivery to the home or office at competitive pricing with traditional pharmacies as well as offers a mobile application for patients to get virtual consultations with pharmacists, enabling users to manage their prescriptions and deliveries from their preferred device.

Onsite power generation for the net-zero carbon grid.

Refuge is a cancer immunotherapy company leveraging synthetic biology and gene engineering to unlock the full promise of cell therapies. We create cell therapies that sense their surroundings and conditionally activate or repress multiple genes simultaneously - resulting in more potent and targeted treatments beyond a single target and function.

Ensighten is the leader in website security and privacy compliance with our comprehensive security solution providing protection against client-side attacks, malicious adware and data loss while protecting privacy and compliance.

Lex Machina provides legal analytics to companies and law firms to craft successful strategies, win cases, and close business. Legal Analytics combines data and software to provide the winning edge in the highly competitive business and practice of law. The company's unique Lexpressions engine creates data sets, never before available about judges, lawyers, parties, and the subjects of lawsuits, out of millions of pages of litigation information. With this data, for the first time, lawyers can predict the behaviors and outcomes that different legal strategies will produce. Lex Machina was founded on 2009 and is based in Menlo Park, California.

Quantifind provides AI solutions for anti-money laundering and fraud detection that uniquely discover risk by combining internal financial institution data with public domain data. Founded in 2008 by two atomic physics Ph.D.s, the company has offices in Silicon Valley, New York, and Washington, DC. For more information, please visit http://www.quantifind.com.

Antheia combines founding intellectual property with world-leading expertise in synthetic biology, informatics, and fermentation technology to provide a stable and cost-competitive supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines.

Vello Systems, Inc., is a leading provider of open programmable application infrastructure software solutions that uniquely allow both Ethernet and optical networks to act as a dynamic pool of resources for ever-changing application requirements, thus simplifying operational complexity and to speeding the deployment of critical enterprise applications. Vello Systems eliminates the complexity of connecting storage and compute systems to improve overall IT performance, reliability, and cost effectiveness. Vello's open networking solutions, with standard programmatic interfaces, integrate seamlessly into leading IT solutions. The Vello family of products is built around the VellOS 7.0 operating environment and OpenFlow-enabled hardware from an ecosystem of partners. Vello solutions have been deployed with blue chip Fortune 500 customers in mission-critical environments. For more information please visit: www.vellosystems.com. Vello Systems, Inc. was founded in 2009 and is based in Menlo Park, California.

Grail develops a pan-cancer screening test designed to detect cancer early. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection.

Joveo delivers the most relevant hires in the shortest time to companies around the world. Providing real-time insights at every step of the job seeker journey from click to hire, our AI-powered job advertising platform dynamically manages and optimizes sourcing and applications across all online channels. Powering 15M+ job postings every day, our machine learning continuously identifies success, learns and improves to reach the talent you need, when you need it. Built for ease of use, Joveo replaces the guesswork, complexity and inefficiency of today's recruiting with intelligence, transparency and efficiency, delivering more relevant candidates, more certainty, more success. Reach them, recruit them, with Joveo.

Strateos automates chemistry, biology, and tissue analysis into closed loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, we enable our pharmaceutical partners to more rapidly and efficiently discover new drug candidates. Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combined automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Strateos was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.

Tusker Medical is a medical platform focused on delivering innovative technology to ear, nose, and throat surgeons and their patients. The company is developing a suite of pediatric-focused technologies designed to enable placement of tubes in the comfort of an office environment, thus avoiding general anesthetics. Tusker Medical's suite of pediatric-focused technologies includes an iontophoresis system to safely and reliably provide needle-free local anesthesia to the tympanic membrane and a tube delivery system designed to provide automated single-button delivery of the tympanostomy tube, enabling placement of tubes within the comfort of an office environment, eliminating the need for general anesthetics. It was founded in 2016 and is headquartered in Menlo Park, California, United States.

Interdisciplinary and international in perspective and preparation of students to lead lives of leadership and service.

Ayasdi Care, an advanced analytics company, offers a machine intelligence platform and intelligent applications to its clients across the world. The company enables its users to solve their big data and complex data analytics challenges and to automate formerly manual processes using their own unique data. Its machine intelligence platform combines scalable computing and big data infrastructure with the machine learning, statistical and geometric algorithms, and topological data analysis to increase its productivity. The company's clientele is comprised of Global 500 corporations, governments, and scientific research institutions. It is licensed on an annual subscription basis.

Synthekine a biotechnology company focused on discovery and developing best in class cytokine therapeutics.